Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

111 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A balance of interleukin-12 and -23 in cancer.
Ngiow SF, Teng MW, Smyth MJ. Ngiow SF, et al. Among authors: teng mw. Trends Immunol. 2013 Nov;34(11):548-55. doi: 10.1016/j.it.2013.07.004. Epub 2013 Aug 13. Trends Immunol. 2013. PMID: 23954142 Review.
Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Haynes NM, et al. Among authors: teng mw. Blood. 2002 Nov 1;100(9):3155-63. doi: 10.1182/blood-2002-04-1041. Blood. 2002. PMID: 12384413
Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ, Darcy PK. Haynes NM, et al. Among authors: teng mw. J Immunol. 2002 Nov 15;169(10):5780-6. doi: 10.4049/jimmunol.169.10.5780. J Immunol. 2002. PMID: 12421958
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes.
Teng MW, Kershaw MH, Moeller M, Smyth MJ, Darcy PK. Teng MW, et al. Hum Gene Ther. 2004 Jul;15(7):699-708. doi: 10.1089/1043034041361235. Hum Gene Ther. 2004. PMID: 15242530
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer.
Kershaw MH, Jackson JT, Haynes NM, Teng MW, Moeller M, Hayakawa Y, Street SE, Cameron R, Tanner JE, Trapani JA, Smyth MJ, Darcy PK. Kershaw MH, et al. Among authors: teng mw. J Immunol. 2004 Aug 1;173(3):2143-50. doi: 10.4049/jimmunol.173.3.2143. J Immunol. 2004. PMID: 15265951
Supernatural T cells: genetic modification of T cells for cancer therapy.
Kershaw MH, Teng MW, Smyth MJ, Darcy PK. Kershaw MH, et al. Among authors: teng mw. Nat Rev Immunol. 2005 Dec;5(12):928-40. doi: 10.1038/nri1729. Nat Rev Immunol. 2005. PMID: 16322746 Review.
CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y. Smyth MJ, et al. Among authors: teng mw. J Immunol. 2006 Feb 1;176(3):1582-7. doi: 10.4049/jimmunol.176.3.1582. J Immunol. 2006. PMID: 16424187
Adoptive transfer of chimeric FcepsilonRI gene-modified human T cells for cancer immunotherapy.
Teng MW, Kershaw MH, Jackson JT, Smyth MJ, Darcy PK. Teng MW, et al. Hum Gene Ther. 2006 Nov;17(11):1134-43. doi: 10.1089/hum.2006.17.1134. Hum Gene Ther. 2006. PMID: 17052145
Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.
Teng MW, Westwood JA, Darcy PK, Sharkey J, Tsuji M, Franck RW, Porcelli SA, Besra GS, Takeda K, Yagita H, Kershaw MH, Smyth MJ. Teng MW, et al. Cancer Res. 2007 Aug 1;67(15):7495-504. doi: 10.1158/0008-5472.CAN-07-0941. Cancer Res. 2007. PMID: 17671220
Interleukin 21 enhances antibody-mediated tumor rejection.
Smyth MJ, Teng MW, Sharkey J, Westwood JA, Haynes NM, Yagita H, Takeda K, Sivakumar PV, Kershaw MH. Smyth MJ, et al. Among authors: teng mw. Cancer Res. 2008 Apr 15;68(8):3019-25. doi: 10.1158/0008-5472.CAN-07-6019. Cancer Res. 2008. PMID: 18413772
111 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback